Alnylam Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	43.57	-278.16	-440.24	-1,131	-852.82	-858.28
Depreciation & Amortization	56.32	56.67	54.05	44.47	89.69	74.44
Loss (Gain) From Sale of Investments	2.47	3.02	16.94	33.31	-55.7	-54.04
Stock-Based Compensation	368.25	272.08	221.68	230.65	165.72	139.87
Other Operating Activities	275.18	152.15	194.46	273.84	174.24	95.76
Change in Accounts Receivable	-603.72	-86.55	-87.94	-45.6	-101.8	-56.24
Change in Inventory	23.18	13.59	18.37	-34.14	-26.42	-35.43
Change in Accounts Payable	187.81	91.09	80.84	191.77	88.24	143.73
Change in Unearned Revenue	-65.75	-235.45	55.02	-65.91	-50.4	-43.97
Change in Other Net Operating Assets	-21.45	3.23	-9.03	-38.51	-72.45	-20.81
Operating Cash Flow	265.86	-8.31	104.16	-541.27	-641.69	-614.96
Capital Expenditures	-44.5	-34.28	-62.21	-72.06	-76.37	-70.36
Investment in Securities	467.35	-63.25	-269.7	254.61	-192.56	-333.96
Other Investing Activities	-2.27	-19.32	-4.44	-13.19	-4.36	-31.2
Investing Cash Flow	420.59	-116.84	-336.35	169.35	-273.3	-435.52
Long-Term Debt Issued	-	-	-	1,016	500	200
Long-Term Debt Repaid	-	-	-	-880.72	-	-
Net Debt Issued (Repaid)	-494.01	-	-	135.39	500	200
Issuance of Common Stock	244.61	302.95	147.46	259.36	246.27	299.98
Other Financing Activities	-70.1	-8.79	24.67	31	500.85	495
Financing Cash Flow	-319.51	294.16	172.13	425.75	1,247	994.98
Foreign Exchange Rate Adjustments	23.37	-15.24	6.39	-7.43	-9.02	4.92
Net Cash Flow	390.3	153.77	-53.67	46.4	323.11	-50.58
Free Cash Flow	221.36	-42.59	41.95	-613.33	-718.07	-685.32
Free Cash Flow Margin	6.90%	-1.89%	2.29%	-59.12%	-85.05%	-139.05%
Free Cash Flow Per Share	1.67	-0.33	0.34	-5.04	-6.06	-5.96
Cash Interest Paid	117.72	67.58	32.12	45.24	24.66	-
Cash Income Tax Paid	8.57	14.36	6.02	2.65	-	-
Levered Free Cash Flow	98.12	197.88	103.55	-444.35	97.11	-777.14
Unlevered Free Cash Flow	199.54	286.54	179.32	-346.87	186.5	-724.33
Change in Working Capital	-479.92	-214.08	57.26	7.62	-162.82	-12.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.